Andrew Hollman Meyer, Chief Business Officer at Janux Therapeutics, Inc. (JANX), sold 50,000 shares at $45.96 ($2.3M) on 2024-09-27, disclosed to the SEC on 2024-09-27.
Open-market sale of $2.3M JANX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| JANX | SELL | 2025-11-14 | $100K | — | Filing → |
| JANX | SELL | 2025-10-30 | $1.0M | — | Filing → |
| JANX | SELL | 2025-05-02 | $200K | — | Filing → |